Dr. Manali I. Patel discusses what people with cancer should know about getting access to advances presented at scientific meetings, including questions to ask your health care team, why access to new advances may not be available right away, and how to get involved with cancer research.
In this podcast, Dr. Maryam Lustberg discusses 3 themes from the 2022 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting, including insights on disparities in access to supportive care, the impacts of COVID-19 on the delivery of supportive care, and clinician burnout.
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in head and neck cancer, brain tumors, and health equity.
Read research from the August 2022 session of the ASCO Plenary Series, which features a study that evaluated how common it is for people with lung cancer to have inherited genetic mutations known to increase cancer risk.
In this podcast, members of the American Society of Clinical Oncology (ASCO) discuss new research presented at the 2022 ASCO Annual Meeting in multiple myeloma, breast cancer, and cancer in people age 60 or older.
In this webinar, experts discuss new research in bladder cancer, kidney cancer, prostate cancer, and testicular cancer presented at the 2022 ASCO Annual Meeting and the 2022 Genitourinary Cancers Symposium.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of notable research that will be presented today. Today’s research includes a study evaluating whether radiation therapy can be avoided after surgery for people aged 55 or older with low-grade luminal A breast cancer, as identified through biomarker testing.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s research includes a study on a targeted therapy combination for treating low-grade childhood glioma with a BRAF V600 mutation.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.
